FDA Approved: OMNITROPE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for OMNITROPE (somatropin) submitted by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Failure Due to Chronic Kidney Disease
• Growth Hormone Deficiency
• Idiopathic Short Stature
• Noonan Syndrome
• Prader-willi Syndrome
• Small For Gestational Age
• Turner Syndrome

Drugs mentioned

• OMNITROPE (somatropin)

Snippet

SUPPL AP for OMNITROPE (SOMATROPIN)